Compare GNTA & PHUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GNTA | PHUN |
|---|---|---|
| Founded | 2014 | 2009 |
| Country | Italy | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.0M | 38.0M |
| IPO Year | N/A | 2016 |
| Metric | GNTA | PHUN |
|---|---|---|
| Price | $1.00 | $1.66 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $7.25 |
| AVG Volume (30 Days) | ★ 625.8K | 209.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $30,883,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $95.95 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 15.57 |
| 52 Week Low | $0.71 | $1.56 |
| 52 Week High | $10.00 | $3.88 |
| Indicator | GNTA | PHUN |
|---|---|---|
| Relative Strength Index (RSI) | 45.25 | 39.38 |
| Support Level | $0.71 | $1.56 |
| Resistance Level | $1.70 | $2.04 |
| Average True Range (ATR) | 0.11 | 0.12 |
| MACD | 0.03 | -0.00 |
| Stochastic Oscillator | 85.53 | 23.08 |
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.
Phunware Inc is a software company. It is a cloud platform for mobile that provides companies with the products, solutions, and data and services necessary to engage, manage and monetize its mobile application audiences. It derives maximum revenue from United States. The company has two reportable segments: Software subscriptions and services; and Advertising. It derives maximum revenue from Software subscriptions and services.